Pharmaceutical manufacturing and formulation development in India.
Annual revenue $360,959 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Indamed Pharmaceuticals

Indamed Pharmaceuticals is a company. Indamed Pharmaceuticals offers products and services including Tablets and Syrup and Suspensions.

Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $360.96 K (USD)
    -46.25
    as on Mar 31, 2024
  • Net Profit
    $11.15 K (USD)
    -55.14
    as on Mar 31, 2024
  • EBITDA
    $78.98 K (USD)
    5.62
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Indamed Pharmaceuticals

Indamed Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Syrup and Suspensions.

Product name locked
Category locked
Primary

Tablets are manufactured for treating various health conditions as part of pharmaceutical formulations.

Product name locked
Category locked
Locked

Syrup and suspensions are provided as liquid formulations intended for patient care in life-threatening diseases.

Funding Insights of Indamed Pharmaceuticals

Premium access

Detailed funding history for Indamed Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Indamed Pharmaceuticals

Investments
Premium access

Investment portfolio details for Indamed Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Indamed Pharmaceuticals

Premium access

Detailed financials for Indamed Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Indamed Pharmaceuticals Comparisons

Indamed Pharmaceuticals Primary company
Description
Pharmaceutical manufacturing and formulation development in ...
Location
-
Founded Year
-
Annual Revenue
$360.96 K (USD)
Net Profit
$11.15 K (USD)
EBITDA
$78.98 K (USD)
Employees
Not available
Premium access

Peer comparison for Indamed Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Indamed Pharmaceuticals

Premium access

Detailed competitors of Indamed Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Indamed Pharmaceuticals

Premium access

Complete news archive for Indamed Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indamed Pharmaceuticals

Annual revenue of Indamed Pharmaceuticals is $360.96K as on Mar 31, 2024.

Indamed Pharmaceuticals was established in 1983 and is regarded as a leading entity in the pharmaceutical sector. Innovative formulations are dedicated by the company to the discovery, development, and commercialization of medicines aimed at enhancing outcomes for patients with life-threatening diseases. High-quality and affordable products, including tablets, syrups, and suspensions, are manufactured and supplied. Third-party products are also provided, reflecting a commitment to improving human life through reliable healthcare solutions. Overseas affiliates are supported with customized product offerings.

Indamed Pharmaceuticals offers Tablets and Syrup and Suspensions.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available